NCT00098033|CompletedPhase 2
Investigation of Clofarabine in Acute Leukemias
Phase II Clinical and Pharmacodynamic Investigation of Clofarabine in Acute Leukemias
Loading search results
Phase II Clinical and Pharmacodynamic Investigation of Clofarabine in Acute Leukemias
Sponsor study identifier
interventional
64
0 countries
N/A
Study Start
September 2002
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
September 2005
Date type not reportedThis date has not been verified as actual or estimated.
The goals and objectives of this project are to evaluate the antileukemic activity of the investigational agent clofarabine in patients with acute myelogenous leukemia (AML), acute lymphocytic leukemia (ALL), and chronic myelogenous leukemia (CML) in accelerated and blastic phases.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2005
Date type not reportedThis date has not been verified as actual or estimated.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2002
Date type not reportedThis date has not been verified as actual or estimated.
December 2, 2004
Actual (reported)December 3, 2004
Actual (reported)September 2005
Date type not reportedThis date has not been verified as actual or estimated.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Cortes JE, Gandhi V, et al. Clofarabine (2-chloro-9-(deoxy-2-fluoro-b-D-arabinosfuranosyl)adenine) is active for patients with refractory or relapsed acute leukemia. #739 ASH 2002.
Hagop M Kantarjian, MD
M.D. Anderson Cancer Center
Jorge E Cortes, MD
M.D. Anderson Cancer Center
First Submitted
December 2, 2004
First Posted
December 3, 2004
Study Start
September 2002
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
September 2005
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
March 25, 2015
Record last verified: 2004-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: